SITC is pleased to host the society’s innovative program designed to foster leadership development, collaborations and scientific exchange among early career investigators who are emerging leaders in the field of cancer immunotherapy: Sparkathon 2.0 Accelerator: Optimizing combination therapy based on immunological mechanisms.
Accepted participants in the Sparkathon Class of 2022 met with luminaries in the field for a two-and-a-half day training June 13-15, 2022. These leaders provided mentorship and the group addressed optimizing combination therapy based on immunological mechanisms. Participants and faculty will also convene at a one-day symposium on Nov. 7, 2022 for additional education and to continue work on program outputs.
Accepted applicants into this elite program will participate for free and receive travel reimbursement to SITC Sparkathon Accelerator. SITC Membership is a requirement for all applicants.
Share this web page or this flyer with other early career scientists who might be interested in applying.